Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Afegostat

Afegostat is a pharmacological chaperone, which specifically and reversibly binds acid-β-glucosidase (GCase) in the endoplasmic reticulum (ER) with high affinity[1].

Product Specifications

CAS Number

[169105-89-9]

Product Name Alternative

D-Isofagomine; Isofagomine

UNSPSC

12352005

Hazard Statement

H315, H319, H320

Target

Glycosidase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/Afegostat.html

Purity

99.96

Solubility

H2O : 4.17 mg/mL (ultrasonic)

Smiles

O[C@@H]1CNC[C@H](CO)[C@H]1O

Molecular Formula

C6H13NO3

Molecular Weight

147.17

Precautions

H315, H319, H320

References & Citations

[1]Richter F, et al. A GCase chaperone improves motor function in a mouse model of synucleinopathy. Neurotherapeutics. 2014 Oct;11 (4) :840-56.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C, 3 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CEP164 Antibody, FITC Conjugated
MBS7114736-01 0.05 mg

CEP164 Antibody, FITC Conjugated

Ask
View Details
CEP164 Antibody, FITC Conjugated
MBS7114736-02 0.1 mg

CEP164 Antibody, FITC Conjugated

Ask
View Details
CEP164 Antibody, FITC Conjugated
MBS7114736-03 5x 0.1 mg

CEP164 Antibody, FITC Conjugated

Ask
View Details
Frozen Tissue Sections, Breast, right
CS553207 5x 5 µm

Frozen Tissue Sections, Breast, right

Ask
View Details
Lentiviral human CPA1 shRNA (UAS) - Lentiviral human CPA1 shRNA (UAS, iRFP) (25)
GTR15347453 1 Vial

Lentiviral human CPA1 shRNA (UAS) - Lentiviral human CPA1 shRNA (UAS, iRFP) (25)

Ask
View Details
TOE1 3'UTR Lenti-reporter-Luc Vector
47278081 1.0 µg

TOE1 3'UTR Lenti-reporter-Luc Vector

Ask
View Details